A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission (Q87355944)
Jump to navigation
Jump to search
scientific article published on 21 September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission |
scientific article published on 21 September 2012 |
Statements
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission (English)
Norbert Vey
Jean-Henri Bourhis
Nicolas Boissel
Dominique Bordessoule
Aude Charbonnier
Anne Etienne
Pascale Andre
François Romagne
Don Benson
Herve Dombret